Purchase Order 75N94021P00851
Award Date 9/8/21
Potential Completion Date 10/1/21
Potential Value $249K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations awarded a firm fixed-price purchase order to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents, to provide a NextSeq 550 sequencing system and associated support plan. The total potential value of the contract is $392,924.00, with a completion date of September 29, 2025. The contract was awarded on a sole-source basis, with no set-aside...
- The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a firm fixed price purchase order contract to Illumina, Inc., a for-profit manufacturer of genetic sequencing systems and related products, to provide a NextSeq 2000 sequencing system. The potential value of the contract is $290,700.00. There was no set-aside designation for this award. Illumina has previously received prime contract awards from federal agencies like the National...
- The Department of Health and Human Services National Institutes of Health (NIH) awarded a firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents, for the supply of an Illumina NextSeq2000 DNA sequencer. The $239,700 contract is intended to support the sequencing and genomic analysis work of the NIH's National Institute on Deafness and Other Communication Disorders (NIDCD) Genomics and Computational Biology Core. The award was...
- The Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse awarded a firm-fixed-price delivery order to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis instruments and reagents. The $451,656.00 contract does not include any set-aside designation. The award supports the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, as well as associated reagents, consumables, sample preparation kits,...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Illumina, Inc. for a NextSeq 2000 Sequencing System or equal, valued at $239,700.00. The requirement was issued through a commercial items solicitation using Simplified Acquisition Procedures, with no set-aside designation. The sequencing system is intended to support the increased workload at the Center for Human Immunology,...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a Firm Fixed Price purchase order to Illumina, Inc., a manufacturer of genetic sequencing systems and related products, for the delivery of an Illumina NextSeq 550 Sequencing System. The potential value of the award is $224,400.00. No set-aside provisions were used. The award was made under a special notice solicitation for an Illumina HiSeq 2500 Sequencer. Illumina has...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) awarded a $178,500.00 firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of genomic analysis instruments and reagents, for the purchase of a NextSeq 500 sequencing system. This award supports the NIH's research and diagnostic needs, as Illumina has provided a range of sequencing systems and consumables to HHS, the Centers for Disease Control and Prevention, the Department of...
- The Department of Health and Human Services National Institutes of Health (NIH) Clinical Center awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $266,475.00 order was for a NextSeq 550 Sequencing System, shipping, maintenance, software licenses, and technical support to support the NIH Clinical Center's Department of Transfusion Medicine and its blood collection and research activities. The contract was...
- The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute awarded a $197,925.00 firm fixed price purchase order for an Illumina NextSeq Sequencing System to Illumina, Inc., a for-profit manufacturer of genomic analysis instruments and reagents. The purchase order was not set aside for any specific business size or type. The award is intended to support the agency's mission by providing a sequencing platform that can increase data output...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $224,400.00 firm fixed price purchase order to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The award is for the provision of a NextSeq 550 Sequencing System with a trade-in of a HiSeq 500 system. This award does not have a set-aside designation. Illumina has previously received prime federal contracts from agencies such as the NIH,...